CENCORA INC (ABG.DE) Stock Price, Forecast & Analysis
Europe - Frankfurt Stock Exchange - FRA:ABG - US03073E1055 - Common Stock
ABG.DE Key Statistics, Chart & Performance
The current stock price of ABG.DE is 287.6 EUR. In the past month the price decreased by -2.66%.
ABG.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| AMP.MI | AMPLIFON SPA | 26.24 | 3.15B | ||
| AXNA.DE | AMPLIFON SPA | 26.19 | 3.14B | ||
| FAGR.BR | FAGRON | 18.55 | 1.60B | ||
| UPR.I | UNIPHAR PLC | 15.82 | 903.30M | ||
| ILM1.DE | MEDIOS AG | 16.99 | 377.04M | ||
| BLC.PA | BASTIDE LE CONFORT MEDICAL | 342.5 | 176.70M | ||
| VMED.DE | VIROMED MEDICAL AG | N/A | 76.55M |
Related stock screener links
About ABG.DE
Company Profile
Cencora, Inc. is a pharmaceutical sourcing and distribution services company. The company is headquartered in Conshohocken, Pennsylvania and currently employs 51,000 full-time employees. The firm helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The firm operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
Company Info
CENCORA INC
1 West First Avenue
Conshohocken PENNSYLVANIA US
Employees: 44000
Phone: 16107277000
CENCORA INC / ABG.DE FAQ
What does ABG do?
Cencora, Inc. is a pharmaceutical sourcing and distribution services company. The company is headquartered in Conshohocken, Pennsylvania and currently employs 51,000 full-time employees. The firm helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The firm operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
What is the current price of ABG stock?
The current stock price of ABG.DE is 287.6 EUR. The price decreased by -0.31% in the last trading session.
Does ABG stock pay dividends?
CENCORA INC (ABG.DE) has a dividend yield of 0.71%. The yearly dividend amount is currently 1.91.
How is the ChartMill rating for CENCORA INC?
ABG.DE has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
How is the market expecting ABG stock to perform?
21 analysts have analysed ABG.DE and the average price target is 333.83 EUR. This implies a price increase of 16.07% is expected in the next year compared to the current price of 287.6.
What is the expected growth for ABG stock?
The Revenue of CENCORA INC (ABG.DE) is expected to grow by 6.24% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Who owns CENCORA INC?
You can find the ownership structure of CENCORA INC (ABG.DE) on the Ownership tab.
ABG.DE Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to ABG.DE.
ABG.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to ABG.DE. Both the profitability and the financial health of ABG.DE get a neutral evaluation. Nothing too spectacular is happening here.
ABG.DE Financial Highlights
Over the last trailing twelve months ABG.DE reported a non-GAAP Earnings per Share(EPS) of 13.61. The EPS increased by 16.21% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.48% | ||
| ROA | 2.03% | ||
| ROE | 103.06% | ||
| Debt/Equity | 5 |
ABG.DE Forecast & Estimates
21 analysts have analysed ABG.DE and the average price target is 333.83 EUR. This implies a price increase of 16.07% is expected in the next year compared to the current price of 287.6.
For the next year, analysts expect an EPS growth of 11.31% and a revenue growth 6.24% for ABG.DE